Pharma channel feed

‘It’ll be a chal­lenge’: BIO chief Crow­ley ad­dress­es seis­mic FDA over­haul

Last month
People
FDA+

Eli Lil­ly sues large com­pound­ing phar­ma­cies Em­pow­er, Strive over tirzepatide prod­ucts

Last month
Health Tech

RFK Jr. has long crit­i­cized drug ads. He just slashed the FDA of­fice that reg­u­lates them

Last month
FDA+
Marketing

Eu­ro­pean drug reg­u­la­tor seeks to ‘stream­line’ biosim­i­lar ap­proval process

Last month
FDA+

Sanofi con­tin­ues its bet on R&D by poach­ing GSK’s head of de­vel­op­ment

Last month
People

Up­dat­ed: J&J’s third talc bank­rupt­cy bid is stopped by Texas fed­er­al judge 

Last month
Law

Fed­er­al judge nix­es FDA's lab-de­vel­oped test rule, says it ex­ceed­ed agen­cy's au­thor­i­ty

Last month
Law

DC court sides with HHS in Ver­tex's fer­til­i­ty pro­gram fight

Last month
Cell/Gene Tx
Law

Mer­ck’s PAH drug cuts risk of se­ri­ous events by 76% in tri­al stopped for ef­fi­ca­cy

Last month
R&D

Lykos’ in­ter­im CEO is set to step down

Last month
R&D

Judge toss­es Am­gen's chal­lenge to Col­orado drug re­view board, says suit is 'too spec­u­la­tive'

Last month
Law

J&J beats Vi­a­tris in patent fight over its an­tipsy­chot­ic drug, staving off com­pe­ti­tion

Last month
Law

CHMP rec­om­mends sev­en la­bel ex­pan­sions and one new ap­proval, re­jects Lil­ly Alzheimer's drug

Last month
FDA+

Mile­stone's shares dive af­ter FDA again re­jects drug for ab­nor­mal heart rhythm

Last month
Manufacturing

Eu­ro­pean reg­u­la­tor re­jects Lil­ly's Alzheimer’s drug over po­ten­tial­ly fa­tal side ef­fects

Last month
FDA+

No­vo inks sec­ond obe­si­ty deal of the week, with Lex­i­con oral drug part­ner­ship worth up to $1B

Last month
Deals

Ex­clu­sive: Met­sera CEO on what it takes to build an obe­si­ty biotech in 2025

Last month
Startups

With tar­iffs on the way, gener­ic drug­mak­ing woes could hin­der Trump’s reshoring plan 

Last month
Manufacturing

Kennedy an­nounces 10,000 job cuts at HHS, with ma­jor re­duc­tions ex­pect­ed at FDA, NIH and CDC

Last month
FDA+

Ex­elix­is’ pri­ma­ry can­cer drug wins FDA ap­proval for neu­roen­docrine tu­mors

2 months ago
R&D

Small biotech joins list of health com­pa­nies tak­ing a trip to Trump's Mar-a-La­go

2 months ago
R&D

J&J touts new sur­vival da­ta pit­ting lung can­cer com­bo against As­traZeneca's ri­val

2 months ago
R&D
Marketing

Trump tar­iffs would in­crease costs for al­most every bio­phar­ma com­pa­ny, sur­vey claims

2 months ago

Sen­ate con­firms Makary as FDA chief with agency cuts, re­turn-to-of­fice in force

2 months ago
R&D
FDA+
First page Previous page 78910111213 Next page Last page
A service from the Financial Times